Skip to main content
. Author manuscript; available in PMC: 2017 Mar 11.
Published in final edited form as: Neuroscience. 2016 Jan 11;317:121–129. doi: 10.1016/j.neuroscience.2016.01.005

Fig. 4. Effect of octoxynol-9 on GTN-induced delayed onset hyperalgesia.

Fig. 4

Administration of the endothelial cell disruptor, octoxynol-9 (0.5% 1 ml/kg body weight, 30 min prior to GTN), markedly attenuated GTN-induced delayed onset mechanical hyperalgesia (one-tailed Student’s t-test, P<0.0001).

HHS Vulnerability Disclosure